Jeffrey M. Bienstock, MD, FAAP, PediatriCare Associates
Articles by Jeffrey M. Bienstock, MD, FAAP, PediatriCare Associates
Emerging Agents for the Treatment of Atopic Dermatitis
ByLawrence F. Eichenfield, MD, Rady Children’s Hospital-San Diego ,Peter A. Lio, MD, Northwestern University Feinberg School of Medicine ,Elizabeth A. Swanson, St. Luke’s Children’s Hospital ,Jeffrey M. Bienstock, MD, FAAP, PediatriCare Associates Lawrence F. Eichenfield, MD; Jeffrey M. Bienstock, MD, FAAP; Peter A. Lio, MD; and Elizabeth A. Swanson, MD, review additional mechanisms being investigated in the pipeline for the treatment of atopic dermatitis.
Accessing Dupilumab for Treatment of AD
ByLawrence F. Eichenfield, MD, Rady Children’s Hospital-San Diego ,Peter A. Lio, MD, Northwestern University Feinberg School of Medicine ,Elizabeth A. Swanson, St. Luke’s Children’s Hospital ,Jeffrey M. Bienstock, MD, FAAP, PediatriCare Associates A discussion on ease of access for dupilumab for the treatment of atopic dermatitis including the process for approval and coverage.
Role of Disease-Modifying Therapy in Atopic Dermatitis
ByLawrence F. Eichenfield, MD, Rady Children’s Hospital-San Diego ,Peter A. Lio, MD, Northwestern University Feinberg School of Medicine ,Elizabeth A. Swanson, St. Luke’s Children’s Hospital ,Jeffrey M. Bienstock, MD, FAAP, PediatriCare Associates Examining the potential role for biologic, dupilumab, in the treatment of moderate to severe atopic dermatitis.
Using Systemic Treatment in Atopic Dermatitis
ByLawrence F. Eichenfield, MD, Rady Children’s Hospital-San Diego ,Peter A. Lio, MD, Northwestern University Feinberg School of Medicine ,Elizabeth A. Swanson, St. Luke’s Children’s Hospital ,Jeffrey M. Bienstock, MD, FAAP, PediatriCare Associates A review of the safety and efficacy of systemic agents such as methotrexate, azathioprine, and cyclosporine in patients with severe, persistent atopic dermatitis.
Role of Nonsteroidal Topical Therapies in AD Management
ByLawrence F. Eichenfield, MD, Rady Children’s Hospital-San Diego ,Peter A. Lio, MD, Northwestern University Feinberg School of Medicine ,Elizabeth A. Swanson, St. Luke’s Children’s Hospital ,Jeffrey M. Bienstock, MD, FAAP, PediatriCare Associates Experts in the management of atopic dermatitis review the safety and efficacy of topical calcineurin inhibitors and topical PDE4 inhibitors.
Management of AD: Nonpharmacological Approaches
ByLawrence F. Eichenfield, MD, Rady Children’s Hospital-San Diego ,Peter A. Lio, MD, Northwestern University Feinberg School of Medicine ,Elizabeth A. Swanson, St. Luke’s Children’s Hospital ,Jeffrey M. Bienstock, MD, FAAP, PediatriCare Associates Peter Lio, MD, and Elizabeth Swanson, MD, provide insight on using nonpharmacological therapies and state-of-the-art skin care treatments for patients with atopic dermatitis.
Patient Factors for Treatment of Atopic Dermatitis
ByLawrence F. Eichenfield, MD, Rady Children’s Hospital-San Diego ,Peter A. Lio, MD, Northwestern University Feinberg School of Medicine ,Elizabeth A. Swanson, St. Luke’s Children’s Hospital ,Jeffrey M. Bienstock, MD, FAAP, PediatriCare Associates Patient factors considered when prescribing treatment options for the management of atopic dermatitis.
New Models of Collaborative Care for Atopic Dermatitis
ByLawrence F. Eichenfield, MD, Rady Children’s Hospital-San Diego ,Peter A. Lio, MD, Northwestern University Feinberg School of Medicine ,Elizabeth A. Swanson, St. Luke’s Children’s Hospital ,Jeffrey M. Bienstock, MD, FAAP, PediatriCare Associates Reviewing the importance of newer models of collaboration between specialty and primary care for atopic dermatitis and educating patients and caregivers for disease management.
Optimizing Multidisciplinary Care for Atopic Dermatitis
ByLawrence F. Eichenfield, MD, Rady Children’s Hospital-San Diego ,Peter A. Lio, MD, Northwestern University Feinberg School of Medicine ,Elizabeth A. Swanson, St. Luke’s Children’s Hospital ,Jeffrey M. Bienstock, MD, FAAP, PediatriCare Associates Lawrence F. Eichenfield, MD; Jeffrey M. Bienstock, MD, FAAP; Peter A. Lio, MD; and Elizabeth A. Swanson, MD, discuss the importance of an integrative approach to care for the management of atopic dermatitis.
Comorbidities With Atopic Dermatitis
ByLawrence F. Eichenfield, MD, Rady Children’s Hospital-San Diego ,Peter A. Lio, MD, Northwestern University Feinberg School of Medicine ,Elizabeth A. Swanson, St. Luke’s Children’s Hospital ,Jeffrey M. Bienstock, MD, FAAP, PediatriCare Associates Elizabeth Swanson, MD, leads the discussion on emerging data on comorbid conditions associated with atopic dermatitis and management in the clinical setting.
Outgrowing Atopic Dermatitis
ByLawrence F. Eichenfield, MD, Rady Children’s Hospital-San Diego ,Peter A. Lio, MD, Northwestern University Feinberg School of Medicine ,Elizabeth A. Swanson, St. Luke’s Children’s Hospital ,Jeffrey M. Bienstock, MD, FAAP, PediatriCare Associates Lawrence F. Eichenfield, MD; Jeffrey M. Bienstock, MD, FAAP; Peter A. Lio, MD; and Elizabeth A. Swanson, MD, discuss whether children outgrow atopic dermatitis and advice for the management of disease.
Diagnosis of Atopic Dermatitis
ByLawrence F. Eichenfield, MD, Rady Children’s Hospital-San Diego ,Peter A. Lio, MD, Northwestern University Feinberg School of Medicine ,Elizabeth A. Swanson, St. Luke’s Children’s Hospital ,Jeffrey M. Bienstock, MD, FAAP, PediatriCare Associates The role of multidisciplinary management in diagnosing atopic dermatitis and when patients typically seek care.
Flare-Ups in Atopic Dermatitis
ByLawrence F. Eichenfield, MD, Rady Children’s Hospital-San Diego ,Peter A. Lio, MD, Northwestern University Feinberg School of Medicine ,Elizabeth A. Swanson, St. Luke’s Children’s Hospital ,Jeffrey M. Bienstock, MD, FAAP, PediatriCare Associates Jeffrey Bienstock, MD, FAAP, identifies the various triggers causing flare-ups for atopic dermatitis in patients.
Pathophysiology of Atopic Dermatitis
ByLawrence F. Eichenfield, MD, Rady Children’s Hospital-San Diego ,Peter A. Lio, MD, Northwestern University Feinberg School of Medicine ,Elizabeth A. Swanson, St. Luke’s Children’s Hospital ,Jeffrey M. Bienstock, MD, FAAP, PediatriCare Associates 
Overview of Atopic Dermatitis (AD)
ByLawrence F. Eichenfield, MD, Rady Children’s Hospital-San Diego ,Peter A. Lio, MD, Northwestern University Feinberg School of Medicine ,Elizabeth A. Swanson, St. Luke’s Children’s Hospital ,Jeffrey M. Bienstock, MD, FAAP, PediatriCare Associates 
Multidisciplinary Management of Atopic Dermatitis
ByLawrence F. Eichenfield, MD, Rady Children’s Hospital-San Diego ,Jeffrey M. Bienstock, MD, FAAP, PediatriCare Associates ,Peter A. Lio, MD, Northwestern University Feinberg School of Medicine ,Elizabeth A. Swanson, St. Luke’s Children’s Hospital 
Advice on Collaborative Care for Atopic Dermatitis
ByLawrence F. Eichenfield, MD, Rady Children’s Hospital-San Diego ,Jeffrey M. Bienstock, MD, FAAP, PediatriCare Associates ,Peter A. Lio, MD, Northwestern University Feinberg School of Medicine ,Elizabeth A. Swanson, St. Luke’s Children’s Hospital 
Approaching Management of Atopic Dermatitis
ByLawrence F. Eichenfield, MD, Rady Children’s Hospital-San Diego ,Jeffrey M. Bienstock, MD, FAAP, PediatriCare Associates ,Peter A. Lio, MD, Northwestern University Feinberg School of Medicine ,Elizabeth A. Swanson, St. Luke’s Children’s Hospital 
Impact of Atopic Dermatitis on Patients and Caregivers
ByLawrence F. Eichenfield, MD, Rady Children’s Hospital-San Diego ,Jeffrey M. Bienstock, MD, FAAP, PediatriCare Associates ,Peter A. Lio, MD, Northwestern University Feinberg School of Medicine ,Elizabeth A. Swanson, St. Luke’s Children’s Hospital 
An Overview of Atopic Dermatitis
ByLawrence F. Eichenfield, MD, Rady Children’s Hospital-San Diego ,Jeffrey M. Bienstock, MD, FAAP, PediatriCare Associates ,Peter A. Lio, MD, Northwestern University Feinberg School of Medicine ,Elizabeth A. Swanson, St. Luke’s Children’s Hospital
Role of Disease-Modifying Therapy in Atopic Dermatitis
Multidisciplinary Management of Atopic Dermatitis
Advice on Collaborative Care for Atopic Dermatitis
Optimizing Multidisciplinary Care for Atopic Dermatitis
Patient Factors for Treatment of Atopic Dermatitis
Management of AD: Nonpharmacological Approaches